Publications de l'unité - UMR9187 / U1196 - Chimie et Modélisation pour la Biologie du Cancer (CMBC) - Institut Curie

Page created by Todd Lane
 
CONTINUE READING
Publications de l’unité
            UMR9187 / U1196 – Chimie et Modélisation pour la Biologie du Cancer
                                                                        (CMBC)

Année de publication : 2020

Paudel B.P., Moye A.L., Assi H.A., El-Khoury R., Cohen S.B., Birrento M.L., Samosorn S.,
Intharapichai K., Tomlinson C.G., Teulade-Fichou M.P., Gonz'alez C., Beck J.L., Damha M.J., van
Oijen A.M., Bryan T.M. (2020 Feb 27)
A mechanism for the extension and unfolding of parallel telomeric G-
quadruplexes by human telomerase at single-molecule resolution
bioRxiv : DOI : 10.1101/2020.02.26.965269

 Résumé

 Telomeric G-quadruplexes (G4) were long believed to form a protective structure at
 telomeres, preventing their extension by the ribonucleoprotein telomerase. Contrary to this
 belief, we have previously demonstrated that parallel-stranded conformations of telomeric
 G4 can be extended by human and ciliate telomerase. However, a mechanistic
 understanding of the interaction of telomerase with structured DNA remained elusive. Here,
 we use single-molecule fluorescence resonance energy transfer (smFRET) microscopy and
 bulk-phase enzymology to propose a mechanism for the resolution and extension of parallel
 G4 by telomerase. Binding is initiated by the RNA template of telomerase interacting with
 the G-quadruplex; nucleotide addition then proceeds to the end of the RNA template. It is
 only through the large conformational change of translocation following synthesis that the G-
 quadruplex structure is completely unfolded to a linear product. Surprisingly, parallel G4
 stabilization with either small molecule ligands or by chemical modification does not always
 inhibit G4 unfolding and extension by telomerase. These data reveal that telomerase is a
 parallel G-quadruplex resolvase.

Marie-Ming Aynaud, Olivier Mirabeau, Nadege Gruel, Sandrine Grossetête, Valentina Boeva,
Simon Durand, Didier Surdez, Olivier Saulnier, Sakina Zaïdi, Svetlana Gribkova, Aziz Fouché,
Ulykbek Kairov, Virginie Raynal, Franck Tirode, Thomas G P Grünewald, Mylene Bohec, Sylvain
Baulande, Isabelle Janoueix-Lerosey, Jean-Philippe Vert, Emmanuel Barillot, Olivier Delattre,
Andrei Zinovyev (2020 Feb 13)
Transcriptional Programs Define Intratumoral Heterogeneity of Ewing Sarcoma
at Single-Cell Resolution.
Cell reports : 1767-1779.e6 : DOI : S2211-1247(20)30074-7

 Résumé

 EWSR1-FLI1, the chimeric oncogene specific for Ewing sarcoma (EwS), induces a cascade of
 signaling events leading to cell transformation. However, it remains elusive how genetically
 homogeneous EwS cells can drive the heterogeneity of transcriptional programs. Here, we
 combine independent component analysis of single-cell RNA sequencing data from diverse
 cell types and model systems with time-resolved mapping of EWSR1-FLI1 binding sites and
 of open chromatin regions to characterize dynamic cellular processes associated with
 EWSR1-FLI1 activity. We thus define an exquisitely specific and direct enhancer-driven

                             INSTITUT CURIE, 20 rue d’Ulm, 75248 Paris Cedex 05, France | 1
Publications de l’unité
            UMR9187 / U1196 – Chimie et Modélisation pour la Biologie du Cancer
                                                                        (CMBC)

 EWSR1-FLI1 program. In EwS tumors, cell proliferation and strong oxidative phosphorylation
 metabolism are associated with a well-defined range of EWSR1-FLI1 activity. In contrast, a
 subpopulation of cells from below and above the intermediary EWSR1-FLI1 activity is
 characterized by increased hypoxia. Overall, our study reveals sources of intratumoral
 heterogeneity within EwS tumors.

Johnson Courtney R. , Steingesser Marc G., Khan Anum, Gladfelter Amy, Bertin Aurélie, McMurray
Michael A. (2020 Jan 28)
Guanidine hydrochloride reactivates an ancient septin hetero-oligomer
assembly pathway in budding yeast
eLife : eLife 2020;9:e54355 : DOI : DOI: 10.7554/eLife.54355

 Résumé

 Septin proteins evolved from ancestral GTPases and co-assemble into hetero-oligomers and
 cytoskeletal filaments. In Saccharomyces cerevisiae, five septins comprise two species of
 hetero-octamers, Cdc11/Shs1–Cdc12–Cdc3–Cdc10–Cdc10–Cdc3–Cdc12–Cdc11/Shs1. Slow
 GTPase activity by Cdc12 directs the choice of incorporation of Cdc11 vs Shs1, but many
 septins, including Cdc3, lack GTPase activity. We serendipitously discovered that guanidine
 hydrochloride rescues septin function in cdc10 mutants by promoting assembly of non-native
 Cdc11/Shs1–Cdc12–Cdc3–Cdc3–Cdc12–Cdc11/Shs1 hexamers. We provide evidence that in S.
 cerevisiae Cdc3 guanidinium occupies the site of a ‘missing’ Arg side chain found in other
 fungal species where (i) the Cdc3 subunit is an active GTPase and (ii) Cdc10-less hexamers
 natively co-exist with octamers. We propose that guanidinium reactivates a latent septin
 assembly pathway that was suppressed during fungal evolution in order to restrict assembly
 to octamers. Since homodimerization by a GTPase-active human septin also creates
 hexamers that exclude Cdc10-like central subunits, our new mechanistic insights likely apply
 throughout phylogeny.

Nishit Srivastava, David Traynor, Matthieu Piel, Alexandre J Kabla, Robert R Kay (2020 Jan 23)
Pressure sensing through Piezo channels controls whether cells migrate with
blebs or pseudopods.
Proceedings of the National Academy of Sciences of the United States of America : DOI :
201905730

 Résumé

 Blebs and pseudopods can both power cell migration, with blebs often favored in tissues,
 where cells encounter increased mechanical resistance. To investigate how migrating cells
 detect and respond to mechanical forces, we used a « cell squasher » to apply uniaxial
 pressure to cells chemotaxing under soft agarose. As little as 100 Pa causes a rapid (
Publications de l’unité
            UMR9187 / U1196 – Chimie et Modélisation pour la Biologie du Cancer
                                                                        (CMBC)

 motility requires extracellular calcium and is accompanied by increased cytosolic calcium. It
 is largely abrogated in cells lacking the Piezo stretch-operated channel; under load, these
 cells persist in using pseudopods and chemotax poorly. We propose that migrating cells
 sense pressure through Piezo, which mediates calcium influx, directing movement with blebs
 instead of pseudopods.

Xavier Sabaté-Cadenas, Alena Shkumatava (2020 Jan 18)
In-Cell Discovery of RNA-Protein Interactions.
Trends in biochemical sciences : DOI : S0968-0004(19)30264-6

 Résumé

Jiawei Wang, Mingpan Cheng, Jielin Chen, Huangxian Ju, David Monchaud, Jean-Louis Mergny, Jun
Zhou (2020 Jan 18)
An oxidatively damaged G-quadruplex/hemin DNAzyme.
Chemical communications (Cambridge, England) : 56 : 1839-1842 : DOI : 10.1039/c9cc09237d

 Résumé

 Oxidative damage of guanine to 8-oxoguanine triggers a partial and variable loss of G-
 quadruplex/hemin DNAzyme activity and provides clues to the mechanistic origins of
 DNAzyme deactivation, which originates from an interplay between decreased G-quadruplex
 stability, lower hemin affinity and a modification of the nature of hemin binding sites.

Decaudin Didier, Frisch Dit Leitz Estelle, Nemati Fariba, Tarin Malcy, Naguez Adnan, Zerara
Mohamed, Marande Benjamin, Vivet-Noguer Raquel, Halilovic Ensar, Fabre Claire, Jochemsen
Aart, Roman-Roman Sergio, Alsafadi Samar. (2020 Jan 9)
Preclinical evaluation of drug combinations identifies co-inhibition of Bcl-2/XL/W
and MDM2 as a potential therapy in uveal melanoma.
European Journal of CancerEuropean Journal of Cancer : DOI : 10.1016/j.ejca.2019.12.012

 Résumé

Allard A, Bouzid M, Betz T, Simon C, Abou-Ghali M, Lemière J, Valentino F, Manzi J, Brochard-
Wyart F, Guevorkian K, Plastino J, Lenz M, Campillo C*, Sykes C* (2020 Jan 1)
Actin modulates shape and mechanics of tubular membranes
bioRxiv : DOI : 10.1101/712505

 Résumé

                             INSTITUT CURIE, 20 rue d’Ulm, 75248 Paris Cedex 05, France | 3
Publications de l’unité
             UMR9187 / U1196 – Chimie et Modélisation pour la Biologie du Cancer
                                                                         (CMBC)

Davidson PM, Battistella A, Déjardin T, Betz T, Plastino J, Cadot B, Borghi N, Sykes C (2020 Jan 1)
Actin accumulates nesprin-2 at the front of the nucleus during confined cell
migration
bioRxiv : DOI : 10.1101/713982

 Résumé

Zuffo M., Gandolfini A., Heddi B., Granzhan A. (2020 Jan 1)
Harnessing intrinsic fluorescence for typing of secondary structures of DNA
bioRxiv : DOI : 10.1101/2020.01.15.907501

 Résumé

 DNA is polymorphic since, despite its ubiquitous presence as a double-stranded helix, it is
 able to fold into a plethora of other secondary structures both in vitro and in cells. Despite
 the considerable advances that have been made in understanding this structural diversity,
 its high-throughput investigation still faces severe limitations. This mainly stems from the
 lack of suitable label-free methods, combining a fast and cheap experimental workflow with
 high information content. Here, we explore the use of intrinsic fluorescence emitted by
 nucleic acids for this scope. After a preliminary assessment of the suitability of this
 phenomenon for tracking the conformational changes of DNA, we examined the intrinsic
 steady-state emission spectra of an 89-membered set of synthetic oligonucleotides with
 reported conformation (G-quadruplexes, i-motifs, single- and double stranded DNA) by
 means of multivariate analysis. Specifically, principal component analysis of emission
 spectra resulted in successful clustering of oligonucleotides into three corresponding
 conformational groups, albeit without discrimination between single- and double-stranded
 structures. Linear discriminant analysis of the same training set was exploited for the
 assessment of new sequences, allowing the evaluation of their G4-forming propensity. Our
 method does not require any labelling agent or dye, avoiding the related intrinsic bias, and
 can be utilized to screen novel sequences of interest in a high-throughput and cost-effective
 manner. In addition, we observed that left-handed (Z-) G4 structures were systematically
 more fluorescent than most other G4 structures, almost reaching the quantum yield of 5′-
 d[(G3T)3G3]-3′ (G3T), the most fluorescent G4 structure reported to date. This property is
 likely to arise from the similar base-stacking geometry in both types of structures.

Année de publication : 2019

Stéphanie Lemaître, Florent Poyer, Paul Fréneaux, Sophie Leboucher, François Doz, Nathalie
Cassoux, Carole D Thomas (2019 Dec 25)
Low retinal toxicity of intravitreal carboplatin associated with good retinal
tumor control in transgenic murine retinoblastoma.
Clinical & experimental ophthalmology : DOI : 10.1111/ceo.13711

                             INSTITUT CURIE, 20 rue d’Ulm, 75248 Paris Cedex 05, France | 4
Publications de l’unité
            UMR9187 / U1196 – Chimie et Modélisation pour la Biologie du Cancer
                                                                        (CMBC)

 Résumé

 Purpose

 Retinoblastoma is a rare intraocular malignancy in children. Current treatments have many
 adverse effects. New therapeutic approaches like intravitreal injections of chemotherapies
 are currently being developed but their toxicities need to be evaluated on animal models.
 This study compares the efficacy and toxicity of intravitreal melphalan, topotecan and
 carboplatin, alone or in combination (sequential administration), in the LHBetaTag
 retinoblastoma mice.

 Methods

 Mice were divided into 9 groups: control, carboplatin 1.5 and 4μg, melphalan 0.1 and 1μg,
 topotecan 0.1 and 1μg, carboplatin 4μg/ topotecan 0.1μg and melphalan 1μg/ topotecan
 0.1μg. The follow‐up was performed using fundus imaging and optical coherence
 tomography combined with histopathological analysis. Absence of tumor and presence of
 calcified tumors were the criteria for therapeutic response assessment. Ocular complications
 were assessed after 4 weekly injections. Retinal toxicity was defined by the decrease of
 retinal thickness and of the number of retinal layers.

 Results

 Topotecan was inactive on retinal tumors. Melphalan (1μg) led to a complete tumor control
 in 91.7% of eyes. Carboplatin strongly decreased the tumor burden (85.7‐93.8% of eyes
 without retinal tumor). The intravitreal injection itself led to ocular complications (25% of
 media opacities and 45.7% of retinal detachment). Only melphalan at 1μg showed a strong
 retinal toxicity. The two combinations showed a good efficacy in reducing the number of
 eyes with retinal tumors with a reduced retinal toxicity.

 Conclusions

 This preclinical study suggests that intravitreal injection of carboplatin has a low toxicity and
 could be evaluated in clinical practice to treat patients suffering from retinoblastoma.

Mouawad L., Beswick V., Jamin N., Montigny C., Quiniou E., Barbot T. (2019 Dec 18)
Deciphering the mechanism of inhibition of SERCA1a by sarcolipin using
molecular simulations
bioRxiv : DOI : 10.1101/2019.12.17.879825

 Résumé

 SERCA1a is an ATPase calcium pump that transports Ca2+ from the cytoplasm to the
 sarco/endoplasmic reticulum lumen. Sarcolipin (SLN), a transmembrane peptide, regulates
 the activity of SERCA1a by decreasing its Ca2+ transport rate, but its mechanism of action is

                             INSTITUT CURIE, 20 rue d’Ulm, 75248 Paris Cedex 05, France | 5
Publications de l’unité
            UMR9187 / U1196 – Chimie et Modélisation pour la Biologie du Cancer
                                                                        (CMBC)

 still not well understood. To decipher this mechanism, we have performed normal modes
 analysis in the all-atom model, with the SERCA1a-SLN complex or the isolated SERCA1a
 embedded in an explicit membrane. The comparison of the results allowed us to provide an
 explanation for the action of SLN that is in good agreement with experimental observations.
 In our analyses, the presence of SLN locally perturbs the TM6 transmembrane helix and as a
 consequence modifies the position of D800, one of the key metal-chelating residues.
 Additionally, it reduces the flexibility of the gating residues, V304 and E309 in TM4, at the
 entrance of the Ca2+ binding sites, which would decrease the affinity for Ca2+.
 Unexpectedly, SLN has also an effect on the ATP binding site more than 35 r A away, due to
 the straightening of TM5, a long helix considered as the spine of the protein. The
 straightening of TM5 modifies the structure of the P-N linker that sits above it, and which
 comprises the 351DKTG354 conserved motif, resulting in an increase of the distance
 between ATP and the phosphorylation site. As a consequence, the turn-over rate could be
 affected. All this gives SERCA1a the propensity to go toward a Ca2+-deprived E2-like state in
 the presence of SLN and toward a Ca2+ high-affinity E1-like state in the absence of SLN,
 although the SERCA1a-SLN complex was crystallized in an E1-like state. In addition to a
 general mechanism of inhibition of SERCA1a regulatory peptides, this study also provides an
 insight in the conformational transition between the E2 and E1 states.

Shensi Shen, Sara Faouzi, Amandine Bastide, Sylvain Martineau, Hélène Malka-Mahieu, Yu Fu,
Xiaoxiao Sun, Christine Mateus, Emilie Routier, Severine Roy, Laurent Desaubry, Fabrice André,
Alexander Eggermont, Alexandre David, Jean-Yves Scoazec, Stéphan Vagner, Caroline Robert
(2019 Dec 18)
An epitranscriptomic mechanism underlies selective mRNA translation
remodelling in melanoma persister cells.
Nature communications : 5713 : DOI : 10.1038/s41467-019-13360-6

 Résumé

 Cancer persister cells tolerate anticancer drugs and serve as the founders of acquired
 resistance and cancer relapse. Here we show that a subpopulation of BRAF mutant
 melanoma cells that tolerates exposure to BRAF and MEK inhibitors undergoes a reversible
 remodelling of mRNA translation that evolves in parallel with drug sensitivity. Although this
 process is associated with a global reduction in protein synthesis, a subset of mRNAs
 undergoes an increased efficiency in translation. Inhibiting the eIF4A RNA helicase, a
 component of the eIF4F translation initiation complex, abrogates this selectively increased
 translation and is lethal to persister cells. Translation remodelling in persister cells coincides
 with an increased N6-methyladenosine modification in the 5′-untranslated region of some
 highly translated mRNAs. Combination of eIF4A inhibitor with BRAF and MEK inhibitors
 effectively inhibits the emergence of persister cells and may represent a new therapeutic
 strategy to prevent acquired drug resistance.

Olivier Brison, Sami El-Hilali, Dana Azar, Stéphane Koundrioukoff, Mélanie Schmidt, Viola Nähse,
Yan Jaszczyszyn, Anne-Marie Lachages, Bernard Dutrillaux, Claude Thermes, Michelle Debatisse,

                             INSTITUT CURIE, 20 rue d’Ulm, 75248 Paris Cedex 05, France | 6
Publications de l’unité
            UMR9187 / U1196 – Chimie et Modélisation pour la Biologie du Cancer
                                                                        (CMBC)

Chun-Long Chen (2019 Dec 15)
Transcription-mediated organization of the replication initiation program across
large genes sets common fragile sites genome-wide.
Nature communications : 5693 : DOI : 10.1038/s41467-019-13674-5

 Résumé

 Common fragile sites (CFSs) are chromosome regions prone to breakage upon replication
 stress known to drive chromosome rearrangements during oncogenesis. Most CFSs nest in
 large expressed genes, suggesting that transcription could elicit their instability; however,
 the underlying mechanisms remain elusive. Genome-wide replication timing analyses here
 show that stress-induced delayed/under-replication is the hallmark of CFSs. Extensive
 genome-wide analyses of nascent transcripts, replication origin positioning and fork
 directionality reveal that 80% of CFSs nest in large transcribed domains poor in initiation
 events, replicated by long-travelling forks. Forks that travel long in late S phase explains CFS
 replication features, whereas formation of sequence-dependent fork barriers or head-on
 transcription-replication conflicts do not. We further show that transcription inhibition during
 S phase, which suppresses transcription-replication encounters and prevents origin resetting,
 could not rescue CFS stability. Altogether, our results show that transcription-dependent
 suppression of initiation events delays replication of large gene bodies, committing them to
 instability.

Année de publication : 2020

Katerina Duskova, Pauline Lejault, Élie Benchimol, Régis Guillot, Sébastien Britton, Anton
Granzhan, David Monchaud (2019 Dec 13)
DNA junction ligands trigger DNA damage and are synthetic lethal with DNA
repair inhibitors in cancer cells
Journal of the American Chemical Society : 142 : 424-435 : DOI : 10.1021/jacs.9b11150

 Résumé

                             INSTITUT CURIE, 20 rue d’Ulm, 75248 Paris Cedex 05, France | 7
Publications de l’unité
          UMR9187 / U1196 – Chimie et Modélisation pour la Biologie du Cancer
                                                                      (CMBC)

Translocation of DNA and RNA polymerases along their duplex substrates results in DNA
supercoiling. This torsional stress promotes the formation of plectonemic structures,
including three-way DNA junction (TWJ), which can block DNA transactions and lead to DNA
damage. While cells have evolved multiple mechanisms to prevent the accumulation of such
structures, stabilizing TWJ through ad hoc ligands offer an opportunity to trigger DNA
damage in cells with high level of transcription and replication, such as cancer cells. Here,
we develop a series of azacryptand-based TWJ ligands, we thoroughly characterize their TWJ-
interacting properties in vitro and demonstrate their capacity to trigger DNA damage in
rapidly dividing human cancer cells. We also demonstrate that TWJ ligands are amenable to
chemically induced synthetic lethality strategies upon association with inhibitors of DNA
repair, thus paving the way towards innovative drug combinations to fight cancers.

                          INSTITUT CURIE, 20 rue d’Ulm, 75248 Paris Cedex 05, France | 8
You can also read